Aurora Cannabis Inc., a prominent Canadian medical cannabis company with a global presence, has officially introduced its first line of inhalable cannabis resin cartridges for patients in the United Kingdom. This marks a significant milestone for Aurora as it continues to broaden its portfolio of innovative medical cannabis products in international markets. With a well-established reputation in Canada and Australia, Aurora is now bringing its proprietary cultivar-specific cannabis extracts to the UK, further demonstrating its commitment to enhancing patient access to high-quality, premium cannabis treatments worldwide.

Trisha Cassidy, Managing Director of Aurora UK and Ireland, highlighted the company’s patient-centric approach, stating, “As a company committed to patient care and feedback, we identified a clear demand for a convenient and discreet cannabis option. We're thrilled to introduce this new product format that maintains our high standards of quality.” Cassidy also emphasized that the launch represents another advancement in Aurora’s mission to provide healthcare professionals with a broader range of reliable medical cannabis options to address the evolving needs of patients in the UK. The company eagerly anticipates feedback from both physicians and patients to refine and expand its offerings.

The new product launch features two 1.2-gram resin cartridges crafted from exclusive and highly sought-after cultivars: Sourdough (indica) and Electric Honeydew (sativa). Designed for inhalation, these cartridges deliver a fast-acting and precisely dosed method of cannabis administration, meeting the growing demand for effective and easily controllable consumption options.

The resin cartridges come with several key advantages:

• Exceptional Flavour Profiles: Leveraging high-quality terpenes and pure extracts, these cartridges offer rich, strain-specific flavours connected to popular flower varieties.

• High Potency: Patients benefit from a powerful and consistent experience with every dose.

• Premium Safety and Quality: Produced in cutting-edge facilities that follow strict TGA-GMP standards, the cartridges are free from additives and exemplify the highest levels of cannabis purity.

• User-Friendly Design: Their portable and discreet format offers ease of use, making them ideal for patients seeking a more convenient method of consumption.

Aurora’s growing range of medical cannabis products is now available throughout the UK. Patients are encouraged to reach out to their healthcare provider or clinic to learn more about these new treatment options. This development further underscores Aurora’s dedication to medical innovation and its ongoing mission to support patient wellness on a global scale.

Aurora is leading the way in opening global access to cannabis, catering to both medical and recreational markets across Canada, Europe, Australia, and New Zealand. Based in Edmonton, Alberta, Aurora is a trailblazer in the international cannabis industry, committed to enhancing lives through the power of cannabis.